Gilead Sciences, Inc. (GILD) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.356 Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2025 earnings 00:00:05.356 -- 00:00:09.400 conference call. My name is Rebecca and I'll be today's host. 00:00:09.400 -- 00:00:14.044 In a moment, we'll begin our prepared remarks, followed by our Q&A session. 00:00:14.044 -- 00:00:19.789 To ask a question, please press star one. To withdraw your question, press star two. 00:00:19.789 -- 00:00:24.593 Now, I'll hand the call over to Jackie Ross, Senior Vice President of Treasury and Investor 00:00:24.593 -- 00:00:26.593 Relations. 00:00:26.635 -- 00:00:31.457 Thank you, Rebecca. Just after market closed today, we issued a press release with earnings 00:00:31.457 -- 00:00:33.819 results for the fourth quarter and full year 2025. 00:00:33.819 -- 00:00:35.340 The 00:00:35.340 -- 00:00:39.564 press release, slides, and supplementary data are available on the Investors section 00:00:39.564 -- 00:00:42.645 of our website at gilead.com. 00:00:43.067 -- 00:00:46.971 The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel 00:00:46.971 -- 00:00:51.955 O'Day, our Chief Commercial and Corporate Affairs Officer, Joanna Mercier, our Chief 00:00:51.955 -- 00:00:57.136 Medical Officer, Dietmar Berger, and our Chief Financial Officer, Andrew Dickinson. 00:00:57.136 -- 00:01:01.661 After that, we'll open the call to Q&A, where the team will be joined by Cindy Peretti, 00:01:01.661 -- 00:01:05.225 the Executive Vice President of KITE. 00:01:05.225 -- 00:01:08.889 Let me remind you that we will be making forward-looking statements. 00:01:08.889 -- 00:01:13.554 Please refer to slide two regarding the risks and uncertainties relating to forward-looking 00:01:13.554 -- 00:01:18.179 statements that ...